Kilitch Drugs Divests Ethiopian Arm for $14 Million to Fund Expansion
Kilitch Drugs India Ltd 路 Press Release 路 23 Oct 2026, 8:45 pm
Kilitch Drugs Divests Ethiopian Arm for $14 Million to Fund Expansion Kilitch Drugs (India) announced on 23rd Oct'26 that it will divest its entire stake in Ethiopian subsidiary Kilitch Estro Biotech PLC to state-owned HarmeeCare Pharmaceuticals for US$14 million, targeted for completion by 31st Jan'27. The company will retain a commercial presence in Ethiopia via a long-term supply and technical services pact. Net proceeds will fund debt reduction and the phased expansion of its Pen, Maharashtra facility for injectables, ophthalmic drops, and GLP-1 therapies targeting regulated export markets under EU GMP and PIC/S standards.
Original exchange filing (PDF)
More announcements from Kilitch Drugs India Ltd
- We are submitting Scrutinizer''s Report for evoting of EGM 路 16 Nov 2026
- Proceeding of EGM held today i.e. 16th November, 2026 路 16 Nov 2026
- Intimation under regulation 30 of the SEBI LODR regulations 2015, corrigendum to the Notice of Extra Ordinary General Meeting 路 13 Nov 2026
- We are submitting herewith the rectification of typo error in the outcome of Board meeting dated 22nd October, 2026 路 13 Nov 2026
- We are submitting herewith the outcome of the Board meeting 路 07 Nov 2026
- Kilitch Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 07 Nov 2026
- Submitting unaudited financials results for quarter ended 30.09.2026 路 07 Nov 2026
- KILITCH DRUGS (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 06-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 06 Nov 2026
